REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,693,000 | -51.3% | 46,646 | -31.5% | 5.31% | -58.6% |
| Q2 2021 | $9,638,000 | -3.3% | 68,100 | -31.9% | 12.82% | -15.6% |
| Q1 2021 | $9,970,000 | -42.4% | 100,000 | -28.6% | 15.20% | -42.9% |
| Q4 2020 | $17,307,000 | +18.4% | 140,000 | -6.7% | 26.62% | +35.7% |
| Q3 2020 | $14,613,000 | -53.4% | 150,000 | -25.4% | 19.62% | -43.1% |
| Q2 2020 | $31,360,000 | +6.8% | 201,000 | -1.2% | 34.45% | +9.2% |
| Q1 2020 | $29,373,000 | -35.3% | 203,500 | -8.3% | 31.55% | +23.7% |
| Q4 2019 | $45,383,000 | +130.7% | 222,000 | -9.4% | 25.50% | +68.0% |
| Q3 2019 | $19,671,000 | -14.9% | 245,000 | 0.0% | 15.18% | -14.8% |
| Q2 2019 | $23,116,000 | +10.4% | 245,000 | 0.0% | 17.80% | -9.8% |
| Q1 2019 | $20,940,000 | +52.3% | 245,000 | 0.0% | 19.75% | +8.2% |
| Q4 2018 | $13,745,000 | -30.0% | 245,000 | +2.1% | 18.25% | -18.4% |
| Q3 2018 | $19,622,000 | +124.4% | 240,000 | -4.0% | 22.37% | +96.9% |
| Q2 2018 | $8,743,000 | +70.5% | 250,000 | 0.0% | 11.36% | +52.0% |
| Q1 2018 | $5,128,000 | -27.6% | 250,000 | 0.0% | 7.47% | +26.9% |
| Q4 2017 | $7,080,000 | -8.9% | 250,000 | 0.0% | 5.89% | -11.3% |
| Q3 2017 | $7,775,000 | -1.7% | 250,000 | 0.0% | 6.64% | -26.1% |
| Q2 2017 | $7,910,000 | +39.7% | 250,000 | 0.0% | 8.98% | +47.5% |
| Q1 2017 | $5,663,000 | +3.8% | 250,000 | 0.0% | 6.09% | -16.1% |
| Q4 2016 | $5,458,000 | +38.0% | 250,000 | +66.7% | 7.26% | +58.8% |
| Q3 2016 | $3,954,000 | +33.4% | 150,000 | 0.0% | 4.57% | +57.6% |
| Q2 2016 | $2,963,000 | – | 150,000 | – | 2.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |